AR023261A1 - EMPLOYMENT OF ARILALCANOILPIRIDAZINAS - Google Patents
EMPLOYMENT OF ARILALCANOILPIRIDAZINASInfo
- Publication number
- AR023261A1 AR023261A1 ARP000101547A ARP000101547A AR023261A1 AR 023261 A1 AR023261 A1 AR 023261A1 AR P000101547 A ARP000101547 A AR P000101547A AR P000101547 A ARP000101547 A AR P000101547A AR 023261 A1 AR023261 A1 AR 023261A1
- Authority
- AR
- Argentina
- Prior art keywords
- hal
- independently represent
- atoms
- substituted
- represent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
El empleo de las arilalcanoilpiridazinas de formula (1), en donde B representa A, OA, NH2, NHA, NAAo un heterociclo aromático con 1 a 4 átomos de N,O y/o S, el cual puede no estar sustituido o estar mono, di o trisustituido con Hal, A y/o OA; Q estáausente o representa alquileno C1-6; R1, R2 representanindependientemente -OH, OR5, -S-R5, -SO-R5, -SO2-R5, Hal, -NO2, -NH2, -NHR5 o -NR5R6; R1 y R2 juntos, también representan -O-CH2-O-; R5 y R6 representanindependientemente A, cicloalquilo C3-7,me tilencicloalquilo C4-8 o alquenilo C2-8; A, A representan independientemente alquilo C1-10, que puede estarsustituido con 1 a 5 átomos de F y/o Cl, y Hal representa F, Cl, Br o I; y/o de sus sales aceptables desde el punto de vista fisiologico,para prepararun medicamento destinado al tratamiento de la osteoporosis, los tumores, la aterosclerosis, la artritis reumatoidea, la esclerosis multiple, ladiabetes mellitus, la colitis ulcerativa y el SIDA. Estos compuestos inhiben selectivamentela fosf odiesterasa IV.The use of the arylalcanoylpyridazines of formula (1), wherein B represents A, OA, NH2, NHA, NAA or an aromatic heterocycle with 1 to 4 atoms of N, O and / or S, which may not be substituted or be mono , di or trisubstituted with Hal, A and / or OA; Q is absent or represents C1-6 alkylene; R1, R2 independently represent -OH, OR5, -S-R5, -SO-R5, -SO2-R5, Hal, -NO2, -NH2, -NHR5 or -NR5R6; R1 and R2 together also represent -O-CH2-O-; R5 and R6 independently represent A, C3-7 cycloalkyl, C4-8 tilecycloalkyl or C2-8 alkenyl; A, A independently represent C1-10 alkyl, which may be substituted with 1 to 5 atoms of F and / or Cl, and Hal represents F, Cl, Br or I; and / or its physiologically acceptable salts, to prepare a medicament for the treatment of osteoporosis, tumors, atherosclerosis, rheumatoid arthritis, multiple sclerosis, ladiabetes mellitus, ulcerative colitis and AIDS. These compounds selectively inhibit phosphodiesterose IV.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19915364A DE19915364A1 (en) | 1999-04-06 | 1999-04-06 | Use of arylalkanoylpyridazines |
Publications (1)
Publication Number | Publication Date |
---|---|
AR023261A1 true AR023261A1 (en) | 2002-09-04 |
Family
ID=7903583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000101547A AR023261A1 (en) | 1999-04-06 | 2000-04-05 | EMPLOYMENT OF ARILALCANOILPIRIDAZINAS |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1143944A3 (en) |
JP (1) | JP2002541095A (en) |
KR (1) | KR20020000550A (en) |
CN (1) | CN1355702A (en) |
AR (1) | AR023261A1 (en) |
AU (1) | AU3811600A (en) |
BR (1) | BR0009549A (en) |
CA (1) | CA2367051A1 (en) |
CZ (1) | CZ20013598A3 (en) |
DE (1) | DE19915364A1 (en) |
HU (1) | HUP0200311A3 (en) |
ID (1) | ID30381A (en) |
MX (1) | MXPA01010034A (en) |
NO (1) | NO20014845L (en) |
PL (1) | PL350963A1 (en) |
RU (1) | RU2001129703A (en) |
WO (1) | WO2000059484A2 (en) |
ZA (1) | ZA200109120B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050096322A1 (en) * | 2002-03-01 | 2005-05-05 | Susumu Igarashi | Nitrogen-containing heterocyclic compound |
DE10224888A1 (en) * | 2002-06-05 | 2003-12-24 | Merck Patent Gmbh | pyridazine |
DE10225574A1 (en) * | 2002-06-10 | 2003-12-18 | Merck Patent Gmbh | New 1-acyl-3-phenyl-5,6-dihydro-4H-pyridazine derivatives, are phosphodiesterase IV inhibitors useful e.g. for treating asthma, allergy, inflammation, autoimmune diseases or myocardial diseases |
US20060173009A1 (en) * | 2003-01-07 | 2006-08-03 | Hiroyuki Kanoh | Agent inducing increase in bone mass |
AR067354A1 (en) | 2007-06-29 | 2009-10-07 | Sunesis Pharmaceuticals Inc | USEFUL COMPOUNDS AS INHIBITORS OF RAF QUINASA |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19632549A1 (en) * | 1996-08-13 | 1998-02-19 | Merck Patent Gmbh | Arylalkanoylpyridazines |
DE19826841A1 (en) * | 1998-06-16 | 1999-12-23 | Merck Patent Gmbh | Arylalkanoylpyridazines |
DE19850701A1 (en) * | 1998-11-04 | 2000-05-11 | Merck Patent Gmbh | Benzoyl pyridazines |
DE19915365A1 (en) * | 1999-04-06 | 2000-10-12 | Merck Patent Gmbh | Tetrahydropyridazine derivatives |
-
1999
- 1999-04-06 DE DE19915364A patent/DE19915364A1/en not_active Withdrawn
-
2000
- 2000-03-15 KR KR1020017011993A patent/KR20020000550A/en not_active Application Discontinuation
- 2000-03-15 ID IDW00200102346A patent/ID30381A/en unknown
- 2000-03-15 JP JP2000609048A patent/JP2002541095A/en active Pending
- 2000-03-15 BR BR0009549-4A patent/BR0009549A/en active Pending
- 2000-03-15 MX MXPA01010034A patent/MXPA01010034A/en not_active Application Discontinuation
- 2000-03-15 RU RU2001129703/15A patent/RU2001129703A/en unknown
- 2000-03-15 PL PL00350963A patent/PL350963A1/en unknown
- 2000-03-15 EP EP00916949A patent/EP1143944A3/en not_active Withdrawn
- 2000-03-15 WO PCT/EP2000/002280 patent/WO2000059484A2/en not_active Application Discontinuation
- 2000-03-15 HU HU0200311A patent/HUP0200311A3/en unknown
- 2000-03-15 CZ CZ20013598A patent/CZ20013598A3/en unknown
- 2000-03-15 AU AU38116/00A patent/AU3811600A/en not_active Abandoned
- 2000-03-15 CN CN00805648A patent/CN1355702A/en active Pending
- 2000-03-15 CA CA002367051A patent/CA2367051A1/en not_active Abandoned
- 2000-04-05 AR ARP000101547A patent/AR023261A1/en unknown
-
2001
- 2001-10-05 NO NO20014845A patent/NO20014845L/en not_active Application Discontinuation
- 2001-11-05 ZA ZA200109120A patent/ZA200109120B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ID30381A (en) | 2001-11-29 |
BR0009549A (en) | 2002-03-26 |
NO20014845D0 (en) | 2001-10-05 |
NO20014845L (en) | 2001-10-05 |
EP1143944A3 (en) | 2002-09-11 |
HUP0200311A2 (en) | 2002-11-28 |
CZ20013598A3 (en) | 2002-01-16 |
JP2002541095A (en) | 2002-12-03 |
ZA200109120B (en) | 2003-11-13 |
MXPA01010034A (en) | 2002-04-24 |
WO2000059484A3 (en) | 2001-08-23 |
CA2367051A1 (en) | 2000-10-12 |
EP1143944A2 (en) | 2001-10-17 |
RU2001129703A (en) | 2004-02-20 |
DE19915364A1 (en) | 2000-10-12 |
KR20020000550A (en) | 2002-01-05 |
PL350963A1 (en) | 2003-02-24 |
AU3811600A (en) | 2000-10-23 |
WO2000059484A2 (en) | 2000-10-12 |
CN1355702A (en) | 2002-06-26 |
HUP0200311A3 (en) | 2002-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2022019I1 (en) | Eribulin or a pharmaceutically acceptable salt thereof - extended SPC | |
UY26727A1 (en) | USEFUL TROPANIC DERIVATIVES IN THERAPY | |
AR038136A1 (en) | CYCLALCANINDOLS WITH REPLACEMENT WITH FLUOR COMPOSITIONS CONTAINING THESE COMPOUNDS AND TREATMENT METHODS | |
ES2485867T3 (en) | Opioid Carboxamide Compounds | |
PE20050130A1 (en) | ORGANIC COMPOUNDS | |
AR040773A1 (en) | USEFUL PIRAZOLS AS INHIBITORS OF GSK-3 | |
CY1110355T1 (en) | Activator of subunit multiplexer subunit activator D | |
ATE506354T1 (en) | SUBSTITUTED ARYLCYCLOPROPYLACETAMIDE AS GLUCOCINASE ACTIVATORS | |
CO5540309A2 (en) | DERIVATIVES OF 4- (FENIL-PIPERAZINIL-METIL) BENZAMIDA AND ITS USES FOR THE TREATMENT OF PAIN, ANXIETY OR GASTROINTESTINAL DISORDERS | |
FI940105A0 (en) | Processes for the preparation of sertraline intermediates | |
ES2184280T3 (en) | INDOL COMPOUNDS AS COX-2 'INHIBITORS. | |
UY29070A1 (en) | FUSIONED HETEROCYCLIC ENANTIOMERS AND THEIR USES | |
AR083017A1 (en) | ESTER PRODUCTIONS OF [3- (1- (1H-IMIDAZOL-4-IL) ETIL) -2-METHYLPHENYL] METHANOL | |
AR040629A1 (en) | HYDRAZON-MALONITRILE DERIVATIVES, THE MEDICINES THAT CONTAIN THEM, USE FOR THE PREPARATION OF A MEDICINAL PRODUCT, A SET OF ELEMENTS (KIT) THAT UNDERSTAND THEM, A PROCEDURE FOR THE PREPARATION, THE USEFUL INTERMEDIARIES IN THIS PROCEDURE, AND A PROCEDURE SAID DERIVATIVES | |
AR023261A1 (en) | EMPLOYMENT OF ARILALCANOILPIRIDAZINAS | |
AR021068A1 (en) | BENZOILPIRIDAZINAS AND PROCEDURES TO PREPARE THEM; PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCEDURE TO PREPARE THEM, AND USE OF DICHASBENZOILPIRIDAZINAS | |
FI851996L (en) | NEW SUBSTITUTES BIS- (4-AMINOPHENYL) -SULPHONER, DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SAOSOM LAEKEMEDEL. | |
AR053989A1 (en) | ESPIRO-HYDANTOINE COMPOUNDS REPLACED WITH PIRIDILE. PHARMACEUTICAL COMPOSITIONS AND OBTAINING PROCESSES. | |
AR019867A1 (en) | USE OF A PIRROLIDINE DERIVATIVE FOR THE MANUFACTURE OF A REPELLENT AGAINST INSECTS, ACAROS AND TICKETS, SUCH COMPOUND, A COMPOSITION THAT LOCOMPRESSES, A PROCESS FOR THE PREPARATION OF SUCH COMPOSITION, AND A PROCESS TO REPELL INSECTS OF PLACES AND PLACES | |
PE20040533A1 (en) | ESTERES IN POSITION 20 OF THE CAMPTOCINES | |
AR066404A1 (en) | NON-NUCLEOSID INHIBITORS OF INVERSE TRANSCRIPT | |
DK0500409T3 (en) | Derivatives of 4-pyrimidinols, their preparation and use in therapy | |
SE8303987L (en) | N-PHENYLPYRAZOLD DERIVATIVES USED AS HERBICIDES | |
AR005549A1 (en) | DERIVATIVES OF 1-PIRAZOL-3-ILETIL-4-INDOL-3-ILPIPERIDINA, A PROCEDURE FOR PREPARING THEM, MEDICINES AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM, A PROCEDURE FOR PREPARING THE PHARMACEUTICAL PREPARATIONS AND USE OF THE SAME MEDICINAL PREPARATIONS FOR THE PREPARATIONS | |
AR045459A1 (en) | REPLACED THIOPHENS AND USES OF THE SAME |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |